MOLECULAR TEMPLATES, INC.

Profile

Company Names

MOLECULAR TEMPLATES, INC.
THRESHOLD PHARMACEUTICALS INC

Addresses

9301 AMBERGLEN BLVD, SUITE 100, AUSTIN, TX 78729

9301 AMBERGLEN BLVD, SUITE 100, AUSTIN, TX 78729

1300 SEAPORT BOULEVARD, SUITE 500, REDWOOD CITY, CA 94063

Phone Numbers

512 869 1555
512 896 1555
650 474 8200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$109,999,992.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-07-17 
$19,999,998.00 
$90,738,000.00 
$70,738,002.00 
Equity 
3
2019-11-18 
$14,999,994.00 
$14,999,994.00 
$0.00 
Equity 
2
2017-08-01 
$40,000,000.00 
$40,000,000.00 
$0.00 
Equity 
1
2009-10-05 
$35,000,000.00 
$35,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
W. 
BIRD 
DIRECTOR
HORIZON THERAPEUTICS INC   |  THRESHOLD PHARMACEUTICALS INC   |  HORIZON PHARMA, INC.   |  THERACOS INC   |  HELIX HOLDINGS I, LLC   |  BLUEBIRD VENTURES I, L.P.   |  NOVOGLIA, INC.   |  SAVANNA BIOTHERAPEUTICS, INC.
MICHAEL 
 
BROXSON 
DIRECTOR
MOLECULAR TEMPLATES, INC.
BRUCE 
C. 
COZADD 
DIRECTOR
THRESHOLD PHARMACEUTICALS INC   |  JAZZ PHARMACEUTICALS INC
JOHN 
G. 
CURD 
EXECUTIVE OFFICER
COLLABRX INC   |  THRESHOLD PHARMACEUTICALS INC
ADAM 
D. 
CUTLER 
EXECUTIVE OFFICER
MOLECULAR TEMPLATES, INC.
JOEL 
A. 
FERNANDES 
EXECUTIVE OFFICER
THRESHOLD PHARMACEUTICALS INC
GABRIELA 
 
GRUIA 
DIRECTOR
MOLECULAR TEMPLATES, INC.   |  APREA THERAPEUTICS, INC.
WILLIAM 
A. 
HALTER 
DIRECTOR
THRESHOLD PHARMACEUTICALS INC   |  OVERSIGHT SYSTEMS, INC.   |  BSR REAL ESTATE INVESTMENT TRUST   |  SCENIC HILL SOLAR XXV, LLC   |  SCENIC HILL SOLAR XXVI, LLC   |  SCENIC HILL SOLAR XV, LLC   |  SCENIC HILL SOLAR XI, LLC   |  SCENIC HILL SOLAR XIV, LLC   |  SCENIC HILL SOLAR XVII, LLC   |  SCENIC HILL SOLAR XXXI, LLC   |  ROCKET SOLAR II, LLC   |  SCENIC HILL SOLAR XVIII, LLC   |  SCENIC HILL SOLAR XLVIII, LLC   |  SCENIC HILL SOLAR LX, LLC   |  SCENIC HILL SOLAR LXI, LLC   |  SCENIC HILL SOLAR LXII, LLC   |  SCENIC HILL SOLAR LIX, LLC   |  SCENIC HILL SOLAR LIV, LLC   |  SCENIC HILL SOLAR L, LLC   |  SCENIC HILL SOLAR LI, LLC
DAVID 
 
HIRSCH 
DIRECTOR
NCRX OPTICAL SOLUTIONS INC   |  PRECISION THERAPEUTICS INC   |  TURIYA MEDIA, INC.   |  CIVITAS THERAPEUTICS, INC.   |  COLLEGIUM PHARMACEUTICAL INC   |  SONGZA, INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  METAMORPHIC VENTURES II, L.P.   |  METAMORPHIC VENTURES II-A, L.P.   |  VOYAT INC.   |  LAUNCHKEY, INC.   |  ONEX YORK CO-INVEST LP   |  COLLEGIUM PHARMACEUTICAL, INC   |  MOVE LOOT, INC.   |  METAMORPHIC VENTURES FD, LLC   |  VELICEPT THERAPEUTICS, INC.   |  GROOP INTERNET PLATFORM INC.   |  ZAVANTE THERAPEUTICS, INC.   |  TRICIDA, INC.   |  MOLECULAR TEMPLATES, INC.   |  POSEIDA THERAPEUTICS, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  SWIFT HOLDCO LTD   |  WKCGRG HOLDINGS, INC.
DAVID 
 
HOFFMAN 
DIRECTOR
NEXT BIG SOUND INC   |  THRESHOLD PHARMACEUTICALS INC   |  ZEBRA IMAGING INC   |  EVENTSORBET, INC.   |  FLYNTLOK, INC.   |  HILDENE OPPORTUNITIES FUND LP   |  HILDENE OPPORTUNITIES FUND II, L.P.   |  FIRST WAVE BIO, INC.   |  HILDENE CREDIT FUND, LP   |  FIRST WAVE BIOPHARMA, INC.   |  DELCATH SYSTEMS, INC.   |  BVC DIGITAL OPPORTUNITIES I, LP   |  MARKETSAI CORP.
DAVID 
 
HOFFMANN 
DIRECTOR
MOLECULAR TEMPLATES, INC.
DAVID 
R. 
HOFFMANN 
DIRECTOR
MOLECULAR TEMPLATES, INC.
WILFRED 
E. 
JAEGER 
DIRECTOR
MOBILE MEDICAL INDUSTRIES, INC.   |  THRESHOLD PHARMACEUTICALS INC
JASON 
 
KIM 
EXECUTIVE OFFICER
CENTER FINANCIAL CORP   |  MOLECULAR TEMPLATES, INC.   |  FRONTIER DENTAL SUPERHOLDINGS, LLC   |  MOLECULAR TEMPLATES, INC.   |  FIREFLY AEROSPACE INC.
JASON 
S. 
KIM 
EXECUTIVE OFFICER
MOLECULAR TEMPLATES, INC.
STEWART 
M. 
KROLL 
EXECUTIVE OFFICER
THRESHOLD PHARMACEUTICALS INC
KEVIN 
 
LALANDE 
DIRECTOR
HOSPITALISTS NOW, INC.   |  D5 PHARMA, INC.   |  TERAPIO CORP   |  SPINAL RESTORATION INC   |  ZENO CORP   |  MOLECULAR TEMPLATES, INC.   |  LDR HOLDING CORP   |  CHANRX CORP.   |  LYRIC PHARMACEUTICALS INC.   |  LAGUNA PHARMACEUTICALS, INC.   |  SANTE CAPITAL FUND, LP   |  CLAIRITY, INC.   |  SENSORIUM THERAPEUTICS, INC.   |  MOLECULAR TEMPLATES, INC.
KEVIN 
M. 
LALANDE 
DIRECTOR
LUMOS PHARMA, INC.   |  MOLECULAR TEMPLATES, INC.
JONATHAN 
 
LANFEAR 
DIRECTOR
MOLECULAR TEMPLATES, INC.
MARK 
D. 
MATTEUCCI 
EXECUTIVE OFFICER
THRESHOLD PHARMACEUTICALS INC
SCOTT 
 
MORENSTEIN 
DIRECTOR
GEMIN X PHARMACEUTICALS INC   |  VALENCE ADVANTAGE LIFE SCIENCES FUND II, L.P.   |  CELATOR PHARMACEUTICALS INC   |  VELICEPT THERAPEUTICS, INC.   |  MOLECULAR TEMPLATES, INC.   |  ANTIOS THERAPEUTICS INC.   |  PRIMMUNE THERAPEUTICS, INC.   |  PALVELLA THERAPEUTICS, INC.
ERIC 
E. 
POMA 
EXECUTIVE OFFICER, DIRECTOR
MOLECULAR TEMPLATES, INC.
ERIC 
 
ROGERS 
EXECUTIVE OFFICER
CULTIVAUNA, LLC   |  MOLECULAR TEMPLATES, INC.   |  SECOND ACT CANNABIS LLC   |  TANDEM TONIC, INC.
CORSEE 
 
SANDERS 
DIRECTOR
MOLECULAR TEMPLATES, INC.
HAROLD 
E. 
SELICK 
EXECUTIVE OFFICER, DIRECTOR
THRESHOLD PHARMACEUTICALS INC   |  CATALYST BIOSCIENCES INC   |  MOLECULAR TEMPLATES, INC.
DAVID 
 
VALACER 
EXECUTIVE OFFICER
MOLECULAR TEMPLATES, INC.
ROGER 
 
WALTZMAN 
EXECUTIVE OFFICER
MOLECULAR TEMPLATES, INC.   |  INDAPTUS THERAPEUTICS, INC.
ROGER 
J. 
WALTZMAN 
EXECUTIVE OFFICER
MOLECULAR TEMPLATES, INC.   |  INDAPTUS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-07-31
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-17 
2019-12-03
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-11-18 
2019-11-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-11-18 
2017-08-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-01 
2017-08-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-01 
2009-10-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2009-10-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
STIFEL, NICOLAUS + COMPANY, INCORPORATED
793
NONE
NONE
MTS SECURITIES, LLC
104059
FINANCIAL WEST GROUP
16668
REEDLAND CAPITAL PARTNERS
NONE